Indefinite Delivery Contract 75N90025D00007
Award Date
1/8/25
Last Date to Order
9/30/25
Federal Agency
NIH Clinical Center
Awardee
Biofire Defense LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract is awarded by the Bureau of Administration, a civilian federal agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of biological agent identification products. The $740,000 IDIQ contract has a period of performance through August 31, 2025 and is for the provision of testing kits and related consumables to support the agency's biodefense and infectious disease diagnostics needs. Several delivery orders have been issued under...
The U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) awarded an Indefinite Delivery Contract (IDC) to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at up to $18.8 million through January 2029, is for the sustainment of the Next Generation Diagnostic System (NGDS) 1. Under this IDC, JPEO-CBD has issued several firm-fixed-price and...
The Indefinite Delivery Contract awarded by the Department of the Air Force Air Combat Command is a single award contract to Biofire Defense LLC for Biofire test kits and reagents. With a potential value of $1.7 million and a period of performance through July 2028, the contract enables the 99th Medical Group to issue delivery orders for diagnostic products over the next five years in support of their biological detection operations. No set-aside was used for this SBIR Phase III contract action....
The Department of State Bureau of Administration awarded a single award indefinite delivery contract to Biofire Defense LLC with a potential value of $600,000. The contract aims to procure Biofire products to support the Department's biological detection and analysis programs. The contract includes four firm fixed price delivery orders placed with Biofire Defense LLC totaling $332,936 for diagnostic consumables. The delivery orders require Biofire to provide Biofire consumables from their...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
This Other Transaction agreement for prototype is awarded by the U.S. Army's Joint PEO Chemical and Biological Defense organization to Biofire Defense LLC, a company that provides biological agent identification products and services. The $22,502,645.71 contract is for an FDA-cleared, reusable, and adaptable diagnostic device to analyze biological warfare agent (BWA) and infectious disease (ID) agents in human clinical specimens. Leveraging Biofire Defense's expertise and past contract awards,...
The federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Biofire Diagnostics LLC, a private biotechnology company specializing in syndromic infectious disease testing. The BPA is against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The BPA has a total ceiling value of $116,004.90 and a...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
This Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and supplies. The $2.1 million single-award IDC covers the delivery of various human leukocyte antigen (HLA) typing and antibody screening reagents to support diagnostics, research protocols, and accreditation maintenance at the NIH Clinical Center through July 2025. No set-aside...